APx Acquisition Corp. I (APXI) 10-K 13 Sep 24 2023 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Sep. 13, 2024	Jun. 30, 2023
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Entity Registrant Name	APx Acquisition Corp. I
Entity Central Index Key	0001868573
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity File Number	001-41125
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	E9
Entity Address, Country	TN
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Title of 12(b) Security	Class A Ordinary Shares, par value $0.0001 per share
Trading Symbol	APXI
Security Exchange Name	NASDAQ
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Interactive Data Current	Yes
Entity Public Float			$ 70.4
Entity Address, Address Line One	714 Westview Avenue
Entity Address, City or Town	Nashville
Entity Address, Postal Zip Code	32705
City Area Code	202
Local Phone Number	465-5882
ICFR Auditor Attestation Flag	false
Auditor Name	Marcum LLP
Auditor Firm ID	688
Auditor Location	Houston, Texas
Document Financial Statement Error Correction [Flag]	false
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A Ordinary Share and one-half of one Redeemable Warrant
Trading Symbol	APXIU
Security Exchange Name	NASDAQ
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share
Trading Symbol	APXIW
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		9,910,124
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		0

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 8,167	$ 413,206
Prepaid expenses	0	137,500
Accrued interest receivable	281,963	577,945
Total Current Assets	290,130	1,128,651
Non-current Investment held in Trust Account	62,406,649	177,952,202
Total Assets	62,696,779	179,080,853
Current liabilities
Accrued expenses and accounts payable	224,903	751,538
Convertible note payable	520,600	0
Total current liabilities	745,503	751,538
Warrant liabilities	878,750	351,500
Total Liabilities	1,624,253	1,103,038
Commitments and Contingencies (Note 8)
Class A ordinary shares - 5,597,624 and 17,250,000 shares subject to possible redemption at $11.20 and 10.35 per share redemption value at December 31, 2023 and 2022, respectively	62,688,612	178,530,147
Shareholders' Deficit
Preferred Stock - $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at December 31, 2023 and 2022	0	0
Additional paid-in capital	0	0
Accumulated Deficit	(1,616,517)	(552,763)
Total Shareholders' Deficit	(1,616,086)	(552,332)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT	62,696,779	179,080,853
Common Class A [Member]
Shareholders' Deficit
Common Stock Value	431	0
Common Class B [Member]
Shareholders' Deficit
Common Stock Value	$ 0	$ 431

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2023	Sep. 30, 2023	Feb. 28, 2023	Dec. 31, 2022
Temporary equity shares outstanding	5,597,624	5,799,120	6,556,583	17,250,000
Temporary Equity, Redemption Price Per Share	$ 11.2			$ 10.35
Preferred stock par or stated value per share	$ 0.0001			$ 0.0001
Preferred stock shares authorized	1,000,000			1,000,000
Preferred stock shares issued	0			0
Preferred stock shares outstanding	0			0
Common Class A [Member]
Temporary equity shares outstanding	5,597,624			17,250,000
Common stock par or stated value per share	$ 0.0001			$ 0.0001
Common stock shares authorized	200,000,000			200,000,000
Common stock shares issued	4,312,500			0
Common stock shares outstanding	4,312,500			0
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001			$ 0.0001
Common stock shares authorized	20,000,000			20,000,000
Common stock shares issued	0			4,312,500
Common stock shares outstanding	0			4,312,500

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Formation costs and other operating expenses	$ 1,744,855	$ 1,118,795
Loss from operations	(1,744,855)	(1,118,795)
Other income (expense):
Interest earned on investments in Trust Account	4,024,613	2,579,253
One-time advisory fee	1,625,000	0
Gain on settlement of deferred underwriting fees	0	249,047
Gain on settlement of debt	117,373	0
Interest expense	(82,345)	0
Change in fair value of warrant liabilities	(562,277)	11,704,950
Gain on settlement of trade payables	878,886	0
Total Other Income (expense), net	6,001,250	14,533,250
Net income	$ 4,256,395	13,414,455
Weighted average shares outstanding diluted	17,575,000
Common Class A [Member]
Other income (expense):
Net income	$ 2,767,853	$ 10,731,564
Weighted average shares outstanding basic	8,018,829	17,250,000
Weighted average shares outstanding diluted	8,018,829	17,250,000
Basic net income per share	$ 0.35	$ 0.62
Diluted net income share	$ 0.35	$ 0.62
Class A And Class B Non Redeemable Common Stock [Member]
Other income (expense):
Weighted average shares outstanding basic	4,312,500	4,312,500
Weighted average shares outstanding diluted	4,312,500	4,312,500
Basic net income per share	$ 0.35	$ 0.62
Diluted net income share	$ 0.35	$ 0.62

Statements of Changes In Shareh

Statements of Changes In Shareholders' Deficit - USD ($)	Total	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Common Class A [Member]	Common Class A [Member] Common Stock [Member]	Common Class B [Member]	Common Class B [Member] Common Stock [Member]
Beginning balance at Dec. 31, 2021	$ (17,175,093)	$ 0	$ (17,175,524)		$ 0		$ 431
Beginning balance (Shares) at Dec. 31, 2021					0		4,312,500
Remeasurement of Class A ordinary shares to redemption amount	(2,580,147)		(2,580,147)
Gain on settlement of underwriting fees	5,788,453		5,788,453
Net income	13,414,455		13,414,455	$ 10,731,564		$ 2,682,891
Ending balance at Dec. 31, 2022	(552,332)	0	(552,763)		$ 0		$ 431
Ending balance (Shares) at Dec. 31, 2022					0		4,312,500
Remeasurement of Class A ordinary shares to redemption amount	(6,024,613)	(704,464)	(5,320,149)
Gain of settlement of trade payables	704,464	704,464	0
Conversion of Class B into Class A shares	0	0	0		$ 431		$ (431)
Conversion of Class B into Class A shares (Shares)					4,312,500		(4,312,500)
Net income	4,256,395		4,256,395	$ 2,767,853		$ 1,488,542
Ending balance at Dec. 31, 2023	$ (1,616,086)	$ 0	$ (1,616,517)		$ 431		$ 0
Ending balance (Shares) at Dec. 31, 2023					4,312,500		0

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities
Net income	$ 4,256,395	$ 13,414,455
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Change in fair value of warrant liabilities	562,277	(11,704,950)
Interest earned on marketable securities held in trust	(4,320,595)	(2,001,308)
Amortization of debt discount	82,345	0
Gain on settlement of debt	(117,373)	0
Gain on settlement of related party payables	(878,886)	0
Gain on settlement of deferred underwriting fees	0	(249,047)
Changes in operating assets and liabilities:
Prepaid expenses	137,500	150,000
Accrued interest receivable	295,982	(577,945)
Accounts payable and accrued expenses	1,056,716	428,569
Net cash provided by (used in) operating activities	1,074,361	(540,226)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(2,000,000)	0
Investment withdrawn from Trust Account	121,866,147	0
Net cash provided by investing activities	119,866,147	0
Cash Flows from Financing Activities:
Proceeds received from promissory note, convertible	520,600	0
Proceeds received from promissory note	1,625,000	0
Repayment of promissory note	(1,625,000)	0
Payments for redemption for class A common stock	(121,866,147)	0
Net cash used in financing activities	(121,345,547)	0
Net change in cash	(405,039)	(540,226)
Cash - Beginning of period	413,206	953,432
Cash - End of Period	8,167	413,206
Non-cash investing and financing activities:
Conversion of class B to class A shares	431	0
Gain on settlement of related party payables	704,464	0
Remeasurement of Class A shares subject to possible redemption	6,024,613	2,580,147
Gain on settlement of underwriting fees	$ 0	$ 5,788,453

Description Of Organization, An

Description Of Organization, And Business Operations And Going Concern	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description Of Organization, And Business Operations And Going Concern	NOTE 1. DESCRIPTION OF ORGANIZATION, AND BUSINESS OPERATIONS AND GOING CONCERN APx Acquisition Corp. I (the “Company”) is a blank check company incorporated in the Cayman Islands on May 13, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2023, the Company had not yet commenced any operations. All activity for the period May 13, 2021 (inception) through December 31, 2023, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) which is described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The Company’s sponsor is APx Cap Sponsor Group I, LLC (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on December 6, 2021. On December 9, 2021, the Company consummated the Initial Public Offering of 17,250,000 units (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $172,500,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 8,950,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $8,950,000 (Note 5). Transaction costs amounted to $10,321,097, consisting of $3,450,000 of underwriting fees, $6,037,500 of deferred underwriting fees and $833,597 of other offering costs. In addition, at December 9, 2021, cash of $1,295,936 was held outside of the Trust Account (as defined below) and is available for working capital purposes. On October 17, 2022, the Company entered into an engagement letter with EarlyBirdCapital, Inc. (“EBC”) for the provision of M&A advisory services (the “Advisory Agreement”) and an engagement letter with EBC for placement agency services (the “Placement Agency Agreement”). Pursuant to the Advisory Agreement, the Company would pay to EBC a fee of $2,000,000 in cash upon the closing of a business combination or similar transaction (the “Transaction Fee”). Pursuant to the Placement Agency Agreement, the Company would pay to EBC upon the closing of a business combination or similar transaction a cash placement fee (the “Placement Agent Fee”) equal to (a) 4.5% of the aggregate equity amount funded by investors contacted by EBC in connection with the placement, and (b) 2.5% of the aggregate debt financing amount, including secured and convertible debt, funded by investors contacted by EBC in connection with the placement. On August 22, 2023, the Company and EBC entered into a letter agreement (the “Letter Amendment”) which terminated the Placement Agency Agreement (including, for the avoidance of doubt, the Placement Agent Fee) and amended the Advisory Agreement. Pursuant to the Letter Amendment, the Advisory Agreement was amended to provide that the Company, at its option, could elect to pay up to $500,000 of the Transaction Fee in ordinary shares of the post-business combination company (in lieu of cash), with such issuance to occur on the six month anniversary of the closing of the business combination, and valued based on the volume weighted average price of the post-business combination company’s ordinary shares for the ten trading days immediately preceding the six month anniversary of the closing of the business combination. On December 21, 2023, the Company received a deficiency letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”). The Letter notified the Company that since the Company had not yet filed its Quarterly Report on Form 10-Q 10-Q First and Second Extension On February 27, 2023, the Company held an extraordinary general meeting (the “February 2023 EGM”) and its shareholders approved an amendment to our amended and restated memorandum and articles of association (as amended, the “Articles of Association”) and to the investment management trust agreement dated as of September 7, 2021 (as amended, the “Trust Agreement”) to change the payment required to extend the Combination Period by two three-month periods (the “February Extension Amendment Amendment”). In connection with such vote, the holders of 10,693,417 public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for an aggregate redemption amount of $111,346,281. Following such redemptions, approximately $68,271,081 remained in the trust account and 6,556,583 public shares remained issued and outstanding. Such remaining amount in the trust account will be distributed either to (i) all holders of public shares upon our liquidation or (ii) holders of public shares who elect to have their shares redeemed in connection with the consummation of our initial business combination. Accordingly, on March 1, 2023, the Company deposited $750,000 into the Trust Account in order to effect the extension of the termination date, from March 9, 2023 to June 9, 2023 (the “First Extension”). On June 22, 2023, the Company deposited an additional $750,000 into the Trust Account for a subsequent extension of the termination date, from June 9, 2023 to September 9, 2023 (the “Second Extension”), that the Company may need to complete an initial business combination. Third Extension On September 7, 2023, the Company held an extraordinary general meeting (the “September 2023 EGM”) and its shareholders approved an amendment to its Articles and to the Trust Agreement to extend the time to complete a business combination (the “Termination Date”) up to three (3) times for an additional one (1) month each time (each, an “Extension”) from September 9, 2023 to December 9, 2023, by depositing the lesser of $0.025 per public share or $125,000 (each such payment, an “Extension Payment”) for each one-month On September 15, 2023, October 19, 2023 and November 13, 2023, the Company deposited $125,000 into the Trust Account in order to effect three one-month Fourth Extension On December 8, 2023, the Company held an extraordinary general meeting (the “December 2023 EGM”) and its shareholders approved an amendment to its Articles and to the Trust Agreement to extend the Termination Date up to twelve (12) times for an additional one (1) month each time from December 9, 2023 to December 9, 2024, by depositing the lesser of $0.025 per public share or $125,000 for each one-month On December 20, 2023, January 24, 2024, February 12, 2024, March 12, 2024, April 8, 2024 and May 28, 2024, the Company deposited $125,000 each month into the Trust Account in order to effect six one-month 10-K, Sponsor Alliance On September 8, 2023, the Company entered into a purchase agreement (the “Purchase Agreement”) with the Company’s sponsor, APx Cap Sponsor Group I, LLC (the “Sponsor”) and Templar, LLC and its designees (the “Purchaser”), whereby the Sponsor transferred to the Purchaser, in exchange for $1.00 plus the Purchaser’s agreement to advance up to $50,000 to pay for expenses related to Company’s Exchange Act filing obligations, 3,342,188 of the Company’s Class B ordinary shares, $0.0001 par value (the “Founder Shares”) and 6,936,250 private placement warrants (the “Placement Warrants”) purchased at the time of the Company’s initial public offering (“IPO”) pursuant to a Private Placement Warrants Purchase Agreement, dated December 6, 2021. The Sponsor retained 970,312 Founder Shares and 2,013,750 Private Placement Warrants. The transfer of Founder Shares and Private Placement Warrants to the Purchaser pursuant to the Purchase Agreement is referred to as the “Transfer,” which closed on September 8. 2023. The Transfer and all transactions consummated in connection there with are referred to as the “Sponsor Alliance Transaction.” On March 21, 2024, in connection with the transfer by Templar LLC of 800,000 Class A ordinary shares of the Company to its wholly owned subsidiary, Templar Subco LLC (“Templar Subco”), Templar Subco entered into a joinder agreement with the Company (the “Joinder Agreement”) to become a party to the Letter Agreement and the Registration Rights Agreement, both dated December 6, 2021 and entered into in connection with the Company’s initial public offering. Upon the closing of the Initial Public Offering, an amount of $175,950,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”) located in the United States and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares without voting, and if they do vote, irrespective of whether they vote for or against a Business Combination. If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Certificate of Incorporation provides that, a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Company’s Sponsor has agreed (a) to vote its Founder Shares (Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association with respect to the Company’s pre-Business pre-Business If the Company is unable to complete a Business Combination by December 9, 2024, 36 months from the closing of the IPO, assuming we further extend the period by up to twelve additional one-month per-share The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Capital Resources As of December 31, 2023 and 2022, the Company had $8,167 and $413,206 in cash and a working capital deficit of $737,336 and $200,832, respectively, excluding accrued interest receivable as it is not available for working capital purposes. The Company’s liquidity needs up to December 31, 2023 had been satisfied through a payment from the Sponsor of $25,000 (Note 6) for the Founder Shares and the remaining net proceeds from our Initial Public Offering, the Private Placement Warrants and the Promissory Notes (as defined below), to cover certain offering expenses. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (Note 7). As of December 31, 2023, there were no amounts outstanding under any Working Capital Loans. On February 28, 2023, the Company issued an unsecured promissory note (the “First Promissory Note”) in the amount of $875,000. The proceeds of the First Promissory Note were drawn in a single instance and will be used to economically facility the Company’s ability to effect the extension of the termination date. The First Promissory Note is payable in full on the earlier of (a) the Company’s consummation of a Business Combination or (b) December 31, 2023. On May 26, 2023, the Company issued a second unsecured promissory note (the “Second Promissory Note”) and, together with the First Promissory Note, the “Promissory Notes”) in the amount of $750,000. The proceeds of the Second Promissory Note were drawn in a single instance and will be used to economically facility the Company’s ability to effect the extension of the termination date. The Second Promissory Note is payable in full on the earlier of (a) the Company’s consummation of a Business Combination or (b) December 31, 2023. On August 18, 2023, the Company paid in full the outstanding balance of $1,625,000 drawn on the First Promissory and Second Promissory Notes, in connection the Company incurred a gain on settlement of debt of $117,373. The Note payable is considered paid in full, and the Company no longer has access to draw funds. On September 8, 2023, in connection with the Sponsor Alliance, the Company issued an unsecured promissory note (the “Working Capital Promissory Note”) in the amount of up to $500,000. The note is non-interest Based on the foregoing, management believes that the Company will not have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. Risks and Uncertainties The military conflict that commenced in February 2022 by the Russian Federation in Ukraine and the surrounding region, and Hamas’ and Iran’s Fall 2023 attack on Israel and the ensuing war, have created and are expected to create further global economic consequences, including but not limited to the possibility of extreme volatility and disruptions in the financial markets, diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. Such global consequences may materially and adversely affect the Company’s ability to consummate an initial Business Combination, or the operations of a target business with which the Company ultimately consummates an initial Business Combination. In addition, the Company’s ability to consummate an initial Business Combination may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the global economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate an initial Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. Going Concern Consideration At December 31, 2023 and 2022, the Company had $8,167 and $413,206 in operating cash and a working capital deficit of $737,336 and $200,832, respectively, excluding Accrued interest receivable as it is not available for working capital purposes. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Account Standards Update (“ASU”) 2014-15, one-month

Revision to Prior Period Financ

Revision to Prior Period Financial Statements	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Revision to Prior Period Financial Statements	NOTE 2. Revision to Prior Period Financial Statements The Company had been recording interest income related to the Trust account based on statements received indicating the receipt of cash into the account. And while the Company had recorded twelve months of interest income, this did not include the effect of period end accruals of interest earned but not received. This resulted in an understatement of income at December 31, 2022 and an understatement of current assets and Class A ordinary shares subject to possible redemption as of December 31, 2022. The Company evaluated the materiality of the error described above from a qualitative and quantitative perspective. Based on this evaluation, taking into account the guidance in the SEC Staff Accounting Bulletin No. 99, “Materiality”, (“SAB 99”) and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” (“SAB 108”), the Company concluded that the correction would not be material to the financial position or results of operations for the year ended December 31, 2022. The audited financial statements as of December 31, 2022, are revised as follows: As Previously Revisions As Revised Balance Sheet as of December 31, 2022 Current assets Accrued interest receivable $ —  $ 577,945 $ 577,945 Total Current Assets 550,706 577,945 1,128,651 TOTAL ASSETS $ 178,502,908 $ 577,945 $ 179,080,853 Commitments and Contingencies (Note 8) Class A ordinary shares - 5,597,624 and 17,250,000 shares subject to possible redemption at $11.20 and 10.35 per share redemption value at December 31, 2023 and 2022, respectively $ 177,952,202 $ 577,945 $ 178,530,147 TOTAL LIABILITIES, CLASS A ORDINARY SHARE SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT $ 178,502,908 $ 577,945 $ 179,080,853   As Previously   Reported  Revisions  As Revised Statement of Operations for the year ended December 31, 2022 Interest earned on investments in Trust Account $ 2,001,308 $ 577,945 $ 2,579,253 Total other income (expense), net 13,955,305 577,945 14,533,250 Net Income $ 12,836,510 $ 577,945 $ 13,414,455 Basic and diluted net income per share, Class $ 0.60 $ 0.02 $ 0.62 Basic and diluted net income per share, Class A and Class B ordinary shares, non-redeemable $ 0.60 $ 0.02 $ 0.62 As Previously Revisions As Revised Statement of Changes in Shareholders’ Deficit for the year ended December 31, 2022 Remeasurement of Class A ordinary shares to redemption amount $ (2,002,202 ) $ (577,945 ) $ (2,580,147 ) Net income 12,836,510 577,945 13,414,455 As Previously Reported Revisions As Revised Statement of Cash Flows for the year ended December 31, 2022 Net Income $ 12,836,510 $ 577,945 $ 13,414,455 Changes in operating assets and liabilities: Accrued interest receivable $ —  $ (577,945 ) $ (577,945 ) Supplemental Disclosures Remeasurement of Class A ordinary shares subject to possible redemption $ 2,002,202 $ 577,945 $ 2,580,147

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $8,167 and $413,206 in cash and no cash equivalents as of December 31, 2023, and 2022, respectively. Investments Held in Trust Account As of December 31, 2023, and 2022, the Company had $62,406,649 and $177,952,202, respectively held in the Trust Account which invests only in direct U.S. government treasury obligations. Share-based Compensation The transfer of the Founder Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, share- based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Share-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon occurrence of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied by the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. As of December 31, 2023 and 2022, the Company determined that a Business Combination is not considered probable and, therefore, no share-based compensation expense has been recognized. The fair value at the grant date of the 40,000 Founder Shares transferred to the Company’s directors was approximately $203,000 or $5.08 per share. Upon consummation of an initial business combination, the Company Net Income Per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 17,575,000 of the Company’s Class A ordinary shares in the calculation of diluted income per share. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company applies the two-class non-redeemable On October 2, 2023, in accordance with the provision of the Articles, each of the APx Sponsor and the Templar Sponsor exercised its rights to convert an aggregate of 4,312,500 Class B ordinary shares into an equal number of Class A ordinary shares, on a one-for-one The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the years ended December 31, 2023 and 2022: For the Year Ended December 31, For the Year Ended December 31 2023 2022 (As Revised) Class A Ordinary Class A and Non-Redeemable Class A Ordinary Class B Ordinary Non-Redeemable Basic and diluted net income per ordinary share Numerator: Allocation of net income $ 2,767,853 $ 1,488,542 $ 10,731,564 $ 2,682,891 Denominator Basic and diluted weighted average shares outstanding 8,018,829 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.35 $ 0.35 $ 0.62 $ 0.62 Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Warrant Liability The Company accounts for warrants based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity” (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, Derivatives and Hedging. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued non-current net-cash Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’ own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were charged to temporary equity and warrants upon the completion of the Initial Public Offering. Offering costs amounting to $10,321,097 were charged to shareholders’ equity upon the completion of the Initial Public Offering and $465,166 were expensed as of the date of the Initial Public Offering. Recently Issued Accounting Standards In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, 470-20) 815-40) 2020-06”) 2020-06 2020-06 if-converted 2020-06 2020-06 In December 2023, the FASB issued ASU No. 2023-09, 2023-09). 2023-09 2023-09 Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholder’s equity. The Company’s ordinary shares outside

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Initial Public Offering	NOTE 4. INITIAL PUBLIC OFFERING On December 9, 2021, the Company sold 17,250,000 Units at $10.00 per Unit, generating gross proceeds of $172.5 million, and incurring offering costs of $10,321,097, consisting of $3,450,000 of underwriting fees, $6,037,500 of deferred underwriting fees and $833,897 of other offering costs. Each Unit consists of one share of the Company’s Class A ordinary shares, par value $0.0001 per share, and one-half ln September 2022, the Company reversed the $6,037,500 of deferred underwriting fees as the underwriters resigned from their role in the Business Combination and thereby waived their right of the deferred underwriting commissions (Note 8).

Private Placement

Private Placement	12 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Private Placement	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased 8,950,000 Private Placement Warrants at a price of $1.00 per warrant, generating total proceeds of $8,950,000 to the Company. Each Private Placement Warrant is identical to the warrants offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the trust account with respect to Private Placement Warrants when the price per share of Class A ordinary shares equals or exceeds $18.00, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period. On September 8, 2023, as part of the Purchase Agreement between the Company’s Sponsor, APx Cap Sponsor Group I, LLC (the “Sponsor”) transferred to Templar, LLC and its designees (the “Purchaser”), 6,936,250 private placement warrants purchased at the time of the Company’s initial public offering (“IPO”) pursuant to a Private Placement Warrants Purchase Agreement dated December 6, 2021. The Sponsor retained 2,013,750 Private Placement Warrants. The transfer was executed as part of the Sponsor Alliance Transaction.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On May 21, 2021, the Company issued an aggregate of 4,312,500 shares of Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. The Founder Shares include an aggregate of up to 562,500 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment is not exercised in full or in part, so that the Sponsor will collectively own, on an as-converted Other than as described above, the Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class 30-trading lock-up. On September 8, 2023, as part of the Purchase Agreement between the Company’s Sponsor, APx Cap Sponsor Group I, LLC (the “Sponsor”) transferred to Templar LLC and its designees (the “Purchaser”), 3,342,188 of the Company’s class B ordinary shares, $0.0001 par value (the “Founder Shares”) purchased at the time of the Company’s initial public offering (“IPO”) pursuant to a Private Placement Warrants Purchase Agreement, dated December 6, 2021. The Sponsor retained 970,312 Founder Shares. The transfer was executed as part of the Sponsor Alliance Transaction. Promissory Note — Related Party On May 21, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Initial Note”). The Initial Note is non-interest During the year ended December 31, 2022, the Company incurred $6,900 of administrative fees that was paid directly by the Sponsor. The Company reimbursed the Sponsor shortly thereafter, therefore there is no related party payable balance outstanding as of December 31, 2023 and 2022. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2023 and 2022, the company has not drawn any balance and no longer has access to draw funds. Administrative Support Agreement Commencing on the date of the prospectus and until completion of the Company’s initial business combination or liquidation, the Company may reimburse an affiliate of the Sponsor up to an amount of $10,000 per month for office space and secretarial and administrative support provided to members of the Company’s management team. The Company considered this agreement under the guidance of ASC 842, Leases, and determined that this agreement did not meet the definition of a lease. In connection with the Sponsor Alliance Transaction, the Company and APx Sponsor Group I terminated the administrative services agreement as of the end of September 2023, and the Company ceased paying these monthly fees.

Promissory Note Payable

Promissory Note Payable	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Promissory Note Payable	NOTE 7. PROMISSORY NOTE PAYABLE On February 28, 2023, the Company issued an unsecured promissory note (the “First Promissory Note”) in an amount of $875,000 in order to economically facilitate their ability to effect the extension of the termination date. An amount of $125,000 was used in order to economically facilitate the extension payment to extend the period from September 9, 2023 to October 9, 2023. The First Promissory Note is payable in full on the earlier of (a) consummation of an initial business combination or (b) December 31, 2023 (the “First Due Date”). On the First Due Date, the Company shall pay to the payee under the First Promissory Note (the “Payee”) the outstanding principal amount of the First Promissory Note in immediately available funds and deliver to the Payee, as interest-in-kind, On May 26, 2023, the Company issued a second unsecured promissory note (the “Second Promissory Note” and, together with the First Promissory Note, the “Promissory Notes”) in an amount of $750,000 in order to economically facilitate the ability to effect the extension of the termination date, from June 9, 2023 to September 9, 2023 (the “Second Extension”). The Second Promissory Note is payable in full on the earlier of (a) consummation of an initial business combination or (b) December 31, 2023 (the “Second Due Date”). On the Second Due Date, the Company shall pay to the Payee under the Second Promissory Note the outstanding principal amount of the Second Promissory Note in immediately available funds and deliver to the Payee, as interest-in-kind, On August 18, 2023, the Company paid in full the outstanding balance of $1,625,000 drawn on the First Promissory and Second Promissory Notes. In connection, the Company incurred a gain on settlement of debt of $117,373. The Promissory Note payable is considered paid in full, and the Company no longer has access to draw funds. The Payee forfeited all newly issued private placement warrants, and there was no debt discount as of December 31, 2023. On September 8, 2023, in connection with the Sponsor Alliance, the Company issued an unsecured promissory note (the “Working Capital Promissory Note”) in the amount of up to $500,000. The note is non-interest On February 9, 2024, the Company and Templar amended and restated the Working Capital Promissory Note (the “Amended and Restated Note”), to increase the maximum principal amount from $500,000 to $2,000,000 and to provide that, in addition to funding working capital needs, amounts under the Amended and Restated Note may be used for the purposes of making one or more payments to Continental Stock Transfer & Trust Company, a New York limited liability trust company, as Extension Payments (as defined in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on November 29, 2023, as amended).

Commitments And Contingencies

Commitments And Contingencies	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	NOTE 8. COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A ordinary shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriter’s Agreement The Company granted the underwriter a 45-day The underwriter was entitled to a cash underwriting discount of 2.00% of the gross proceeds of the Initial Public Offering, or $3,450,000 as the over-allotment option was exercised in full. In addition, the underwriter would be entitled to a deferred fee of three and half percent (3.50%) of the gross proceeds of the Initial Public Offering, or $6,037,500 as the over-allotment option was exercised in full. The deferred fee would become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Effective as of September 28, 2022, the underwriter from the Initial Public Offering resigned and withdrew from their role in the Business Combination and thereby waived their right to the deferred underwriting commissions in the amount of $6,037,500, which the Company has recorded as a gain on settlement of underwriter fees on the statement of shareholders’ equity for the year ended December 31, 2022 for $5,788,453, which represents the original amount recorded to accumulated deficit, and the remaining balance representing the original amount recorded to the statements of operations of $249,047 was recorded for the year ended December 31, 2022. As of December 31, 2023, there are no underwriting commissions outstanding. Advisory Agreement On October 17, 2022, the Company had entered into an engagement letter with EarlyBirdCapital, Inc. (“EBC”) for the provision of M&A advisory services (the “Advisory Agreement”) which was subsequently amended on August 22, 2023. The Advisory Agreement was amended to provide that the Company at its option, could elect to pay up to $500,000 of the transaction fee in ordinary shares of the post-business combination company (in lieu of cash), with such issuance to occur on the six month anniversary of the closing of the business combination, and valued based on the volume weighted average price of the post business combination company’s ordinary shares for the ten trading days immediately preceding the six month anniversary of the closing of the business combination. Structuring Services Agreement On May 18, 2023, Grupo Promotor de Desarrollo e Infraestructura, S.A. de C.V. (“Prodi Capital”) engaged the Company to act as a structuring agent in connection with potential transaction related to a business combination. The Company will be entitled to customary fees in such capacity, with payment due upon finalization of the advisory services. In connection with the Sponsor Alliance Transaction (see Note 1), the Company ended the services agreement. For the year ended December 31, 2023, the Company received $1,625,000 for services rendered in relation to this agreement.

Warrant Liability

Warrant Liability	12 Months Ended
	Dec. 31, 2023
Warrants and Rights Note Disclosure [Abstract]
Warrant Liability	NOTE 9. WARRANT LIABILITY The Company accounted for the 17,575,000 warrants issued in connection with the Public Offering (8,625,000 Public Warrants and 8,950,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. re-measurement re-measurement, Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to file with the SEC a registration statement covering the shares of Class A ordinary shares issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 Once the warrants become exercisable, the Company may redeem the Warrants for redemption: • in whole and not in part; • at a price of $0.01 per Warrant; • upon a minimum of 30 days’ prior written notice of redemption, which we refer to as the 30-day • if, and only if, the closing price of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, 30-trading The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 Once the Warrants become exercisable, the Company may redeem the Warrants for redemption: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive the number of shares determined by reference to the table set forth under “Description of Securities—Warrants—Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined below); • if, and only if, the Reference Value (as defined above under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted for share sub-divisions, • if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price. The Private Placement Warrants will be identical to the Public Warrants included in the Units being sold in the Initial Public Offering, except that the Private Placement Warrants will not and the shares of common shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable

Shareholders' Deficit

Shareholders' Deficit	12 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	NOTE 10. SHAREHOLDERS’ DEFICIT Preferred Shares Class A Ordinary shares – Class B Ordinary shares The shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the Business Combination on a one-for-one On October 2, 2023, the Company entered into a Share Exchange Agreement with the Purchaser and the Sponsor (the “Share Exchange Agreement”), pursuant to which each of the Purchaser and the Sponsor exchanged (the “Share Exchange”) all Class B ordinary shares then held (totaling an aggregate of 4,312,500 shares) into Class A ordinary shares. The Company issued 4,312,500 Class A ordinary shares (the “Exchange Shares”) in connection with the Share Exchange. As a result of the Class B Conversion, no Class B ordinary shares remain outstanding as of December 31, 2023. The offer and sale of the Exchange Shares has not been registered under the Securities Act or any state securities laws and the Exchange Shares not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption from registration requirements. Nothing contained in this Annual Report on Form 10-K In the Share Exchange Agreement, each of the Purchaser and the Sponsor represented to the Company that it is an “accredited investor”, as defined in Rule 501 promulgated under the Securities Act, and the Company’s offer and sale of the Exchange Shares have been made in reliance upon the exemption from the registration requirements of the Securities Act. The Company may issue additional ordinary shares or preferred share to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	12 Months Ended
	Dec. 31, 2023
Temporary Equity Disclosure [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	NOTE 11. CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit. In February of 2023, in connection with the vote to approve the First Extension and the Trust Amendment, the holders of 10,693,417 Public Shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of $111,346,281. Following such redemptions, approximately $68,271,081 remained in the trust account and 6,556,583 public shares remained issued and outstanding. Such remaining amount in the trust account will be distributed either to (i) all holders of public shares upon our liquidation or (ii) holders of public shares who elect to have their shares redeemed in connection with the consummation of our initial business combination. Accordingly, on March 1, 2023, the Company deposited $750,000 into the Trust Account in order to effect the extension of the termination date, from March 9, 2023 to June 9, 2023 (the “First Extension”). On June 22, 2023, the Company deposited an additional $750,000 into the Trust Account for a subsequent extension of the termination date, from June 9, 2023 to September 9, 2023 (the “Second Extension”). In September of 2023, in connection with the shareholders’ vote at the Extraordinary General Meeting, the holders of 757,463 public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $10.92 per share, for an aggregate redemption amount of approximately $8,273,281. Following such redemptions 5,799,120 public shares remained issued and outstanding. The remaining amount in the Trust Account will be distributed either to: (i) all of the holders of shares of Class A ordinary shares issued as part of the units sold in the Initial Public Offering (the “Public Shares”) upon the Company’s liquidation or (ii) holders of Public Shares who elect to have their shares redeemed in connection with the consummation of a Business Combination. In connection with the December 2023 EGM, the holders of 201,496 public shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for an aggregate redemption amount of $2,246,585. Following such redemptions, $62,410,856 remained in the trust account and 5,597,624 public shares remained issued and outstanding. Such remaining amount in the trust account will be distributed either to (i) all holders of public shares upon our liquidation or (ii) holders of public shares who elect to have their shares redeemed in connection with the consummation of our initial business combination. At December 31, 2023 and 2022, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table: Class A ordinary shares subject to possible redemption at December 31, 2021 $ 175,950,000 Add: Remeasurement of carrying value to redemption value, as revised 2,580,147 Class A ordinary shares subject to possible redemption at December 31, 2022, as revised $ 178,530,147 Less: Shares redeemed in February 2023 (111,346,281 ) Shares redeemed in September 2023 (8,273,281 ) Shares redeemed in December 2023 (2,246,585 ) Add: Remeasurement of carrying value to redemption value 6,024,612 Class A ordinary shares subject to possible redemption at December 31, 2023 $ 62,688,612

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 12. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Level December 31, 2023 December 31, 2022 Assets: Investments held in Trust Account – (1) 1 $ 62,406,649 $ 177,952,202 Liabilities: Warrant Liability - Public Warrants (2) 1 $ 431,250 $ 172,500 Warrant Liability - Private Warrants (2) 2 $ 447,500 $ 179,000 (1) The fair value of the investments held in Trust Account approximates the carrying amount primarily due to the short-term nature. (2) Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level I measurement during the year ended December 31, 2022 when the Public Warrants were separately listed and traded in an active market. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 measurement during the year ended December 31, 2022, as the key inputs to the valuation model became directly or indirectly observable from the Public Warrants listed price. There were no transfers during the year ended December 31, 2023. Warrants The Warrants are accounted for as liabilities in accordance with ASC 815-40 Initial Measurement The Warrants were valued using a Monte Carlo simulation model-based approach, which is considered to be a Level 3 fair value measurement. The Monte Carlo simulation model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the ordinary shares. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: Inputs December 9, Risk-free interest rate 1.26 % Expected term (years) 5.0 Expected volatility 15.0 % Exercise price $ 11.50 Stock price $ 9.59 The Company’s use of a Monte Carlo simulation model required the use of subjective assumptions: • The risk-free interest rate assumption was based on the five-year U.S. Treasury rate, which was commensurate with the contractual term of the Warrants, which expire on the earlier of (i) five years after the completion of the initial business combination and (ii) upon redemption or liquidation. An increase in the risk-free interest rate, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. • The expected term was determined to be five years, in-line • The expected volatility assumption was based on the implied volatility from a set of comparable publicly-traded warrants as determined based on the size and proximity of business combinations by similar special purpose acquisition companies. An increase in the expected volatility, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. • The fair value of the Units, which each consist of one Class A ordinary share and one-half Subsequent Measurement The Warrants are measured at fair value on a recurring basis. At the subsequent measurement date of December 31, 2023, and 2022, the Private Placement Warrants were fair valued using the Monte Carlo Simulation Method. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants are as follows at subsequent measurement: Inputs December 31, December 31, Risk-free interest rate 3.88 % 4.08 % Expected term (years) .43 .83 Expected volatility .55 % .35 % Exercise price $ 11.50 $ 11.50 Stock price $ 11.18 $ 10.27 Dividend Yield 0.00 % 0.00 % Expected Term to Maturity Date 5.20 4.25 Probability of a successful merger 90.00 % 70.00 % The following table presents the changes in the fair value of the Level 2 warrant liabilities: Private Placement Fair value as of December 31, 2022 $ 179,000 Change in valuation inputs or other assumptions 268,500 Fair value as of December 31, 2023 $ 447,500 (1) Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liabilities in the statements of operations.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	NOTE 13. SUBSEQUENT EVENTS The Company evaluated events that have occurred after the balance sheet date up through the date the financial statements was issued. Based upon the review, management did not identify, other than what has already been disclosed as part of the financial statement footnotes including the below, any subsequent events that would have required adjustment or disclosure in the financial statements. Sponsor Alliance On March 21, 2024, in connection with the transfer by Templar LLC (the “Sponsor”) of 800,000 Class A ordinary shares of APX Acquisition Corp. I (the “Company”) to the Sponsor’s wholly owned subsidiary, Templar Subco LLC (“Sponsor Subco”), Sponsor Subco entered into a joinder agreement with the Company (the “Joinder Agreement”) to become a party to the Letter Agreement and the Registration Rights Agreement, both dated December 6, 2021 and entered into in connection with the Company’s initial public offering. Business Combination On March 25, 2024, the Company, OmnigenicsAI Corp (“OmnigenicsAI”), a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd (“MultiplAI”), a UK-based AI-enabled preventive close mid-year, subject AI-driven Nasdaq Notices On May 30, 2024, the Company received a deficiency letter (the “Report Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”). The Report Letter notified the Company that since the Company had not yet filed its Annual Report on Form 10-K Form 10-Q for On July 24, 2024, the Company submitted its plan to regain compliance with respect to its failure to timely file its Annual Report on Form 10-K 10-Q 180-day On September 4, 2024, the Company received a deficiency letter (the “Warrant Letter”) from Nasdaq. The Warrant Letter notified the Company had failed to maintain a minimum of $1,000,000 in aggregate market value of its outstanding warrants and is not in compliance with Nasdaq’s Listing Rule 5452(b)(C). The Warrant Letter further stated that the Company Bioceres Note On August 26, 2024, the Company issued an unsecured promissory note (the “Bioceres Note”) in the principal amount of $446,000 to Bioceres LLC (“Bioceres”), an indirect shareholder of OmnigenicsAI Corp, the counterparty to the Company’s previously announced business combination. The Note bears interest at 20% per annum. The Company shall repay all interested accrued and the principal balance on the date on which the Company consummates its initial business combination. The Note is subject to customary events of default, the occurrence of certain of which automatically triggers the unpaid principal balance of the Note as well as all accrued interest and all other sums payable with regard to the Note becoming immediately due and payable.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $8,167 and $413,206 in cash and no cash equivalents as of December 31, 2023, and 2022, respectively.
Investments Held in Trust Account	Investments Held in Trust Account As of December 31, 2023, and 2022, the Company had $62,406,649 and $177,952,202, respectively held in the Trust Account which invests only in direct U.S. government treasury obligations.
Share-based Compensation	Share-based Compensation The transfer of the Founder Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, share- based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Share-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon occurrence of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied by the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. As of December 31, 2023 and 2022, the Company determined that a Business Combination is not considered probable and, therefore, no share-based compensation expense has been recognized. The fair value at the grant date of the 40,000 Founder Shares transferred to the Company’s directors was approximately $203,000 or $5.08 per share. Upon consummation of an initial business combination, the Company
Net Income Per Ordinary Share	Net Income Per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 17,575,000 of the Company’s Class A ordinary shares in the calculation of diluted income per share. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company applies the two-class non-redeemable On October 2, 2023, in accordance with the provision of the Articles, each of the APx Sponsor and the Templar Sponsor exercised its rights to convert an aggregate of 4,312,500 Class B ordinary shares into an equal number of Class A ordinary shares, on a one-for-one The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the years ended December 31, 2023 and 2022: For the Year Ended December 31, For the Year Ended December 31 2023 2022 (As Revised) Class A Ordinary Class A and Non-Redeemable Class A Ordinary Class B Ordinary Non-Redeemable Basic and diluted net income per ordinary share Numerator: Allocation of net income $ 2,767,853 $ 1,488,542 $ 10,731,564 $ 2,682,891 Denominator Basic and diluted weighted average shares outstanding 8,018,829 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.35 $ 0.35 $ 0.62 $ 0.62
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Warrant Liability	Warrant Liability The Company accounts for warrants based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity” (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, Derivatives and Hedging. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued non-current net-cash
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’ own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were charged to temporary equity and warrants upon the completion of the Initial Public Offering. Offering costs amounting to $10,321,097 were charged to shareholders’ equity upon the completion of the Initial Public Offering and $465,166 were expensed as of the date of the Initial Public Offering.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, 470-20) 815-40) 2020-06”) 2020-06 2020-06 if-converted 2020-06 2020-06 In December 2023, the FASB issued ASU No. 2023-09, 2023-09). 2023-09 2023-09 Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholder’s equity. The Company’s ordinary shares outside

Revision to Prior Period Fina_2

Revision to Prior Period Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Summary Of Audited Financial Statements	The audited financial statements as of December 31, 2022, are revised as follows: As Previously Revisions As Revised Balance Sheet as of December 31, 2022 Current assets Accrued interest receivable $ —  $ 577,945 $ 577,945 Total Current Assets 550,706 577,945 1,128,651 TOTAL ASSETS $ 178,502,908 $ 577,945 $ 179,080,853 Commitments and Contingencies (Note 8) Class A ordinary shares - 5,597,624 and 17,250,000 shares subject to possible redemption at $11.20 and 10.35 per share redemption value at December 31, 2023 and 2022, respectively $ 177,952,202 $ 577,945 $ 178,530,147 TOTAL LIABILITIES, CLASS A ORDINARY SHARE SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT $ 178,502,908 $ 577,945 $ 179,080,853   As Previously   Reported  Revisions  As Revised Statement of Operations for the year ended December 31, 2022 Interest earned on investments in Trust Account $ 2,001,308 $ 577,945 $ 2,579,253 Total other income (expense), net 13,955,305 577,945 14,533,250 Net Income $ 12,836,510 $ 577,945 $ 13,414,455 Basic and diluted net income per share, Class $ 0.60 $ 0.02 $ 0.62 Basic and diluted net income per share, Class A and Class B ordinary shares, non-redeemable $ 0.60 $ 0.02 $ 0.62 As Previously Revisions As Revised Statement of Changes in Shareholders’ Deficit for the year ended December 31, 2022 Remeasurement of Class A ordinary shares to redemption amount $ (2,002,202 ) $ (577,945 ) $ (2,580,147 ) Net income 12,836,510 577,945 13,414,455 As Previously Reported Revisions As Revised Statement of Cash Flows for the year ended December 31, 2022 Net Income $ 12,836,510 $ 577,945 $ 13,414,455 Changes in operating assets and liabilities: Accrued interest receivable $ —  $ (577,945 ) $ (577,945 ) Supplemental Disclosures Remeasurement of Class A ordinary shares subject to possible redemption $ 2,002,202 $ 577,945 $ 2,580,147

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Summary of Basic and Diluted Net Income Loss Per Common Share	The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the years ended December 31, 2023 and 2022: For the Year Ended December 31, For the Year Ended December 31 2023 2022 (As Revised) Class A Ordinary Class A and Non-Redeemable Class A Ordinary Class B Ordinary Non-Redeemable Basic and diluted net income per ordinary share Numerator: Allocation of net income $ 2,767,853 $ 1,488,542 $ 10,731,564 $ 2,682,891 Denominator Basic and diluted weighted average shares outstanding 8,018,829 4,312,500 17,250,000 4,312,500 Basic and diluted net income per ordinary shares $ 0.35 $ 0.35 $ 0.62 $ 0.62

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	12 Months Ended
	Dec. 31, 2023
Temporary Equity Disclosure [Abstract]
Summary of Class A Ordinary Shares Subject to possible Redemption	At December 31, 2023 and 2022, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table: Class A ordinary shares subject to possible redemption at December 31, 2021 $ 175,950,000 Add: Remeasurement of carrying value to redemption value, as revised 2,580,147 Class A ordinary shares subject to possible redemption at December 31, 2022, as revised $ 178,530,147 Less: Shares redeemed in February 2023 (111,346,281 ) Shares redeemed in September 2023 (8,273,281 ) Shares redeemed in December 2023 (2,246,585 ) Add: Remeasurement of carrying value to redemption value 6,024,612 Class A ordinary shares subject to possible redemption at December 31, 2023 $ 62,688,612

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Level December 31, 2023 December 31, 2022 Assets: Investments held in Trust Account – (1) 1 $ 62,406,649 $ 177,952,202 Liabilities: Warrant Liability - Public Warrants (2) 1 $ 431,250 $ 172,500 Warrant Liability - Private Warrants (2) 2 $ 447,500 $ 179,000 (1) The fair value of the investments held in Trust Account approximates the carrying amount primarily due to the short-term nature. (2) Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level I measurement during the year ended December 31, 2022 when the Public Warrants were separately listed and traded in an active market. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 measurement during the year ended December 31, 2022, as the key inputs to the valuation model became directly or indirectly observable from the Public Warrants listed price. There were no transfers during the year ended December 31, 2023.
Summary of Fair Value Measurements Inputs	The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: Inputs December 9, Risk-free interest rate 1.26 % Expected term (years) 5.0 Expected volatility 15.0 % Exercise price $ 11.50 Stock price $ 9.59 The key inputs into the Monte Carlo simulation model for the Private Placement Warrants are as follows at subsequent measurement: Inputs December 31, December 31, Risk-free interest rate 3.88 % 4.08 % Expected term (years) .43 .83 Expected volatility .55 % .35 % Exercise price $ 11.50 $ 11.50 Stock price $ 11.18 $ 10.27 Dividend Yield 0.00 % 0.00 % Expected Term to Maturity Date 5.20 4.25 Probability of a successful merger 90.00 % 70.00 %
Summary of Changes in the Fair Value of Level 2 Warrant Liabilities	The following table presents the changes in the fair value of the Level 2 warrant liabilities: Private Placement Fair value as of December 31, 2022 $ 179,000 Change in valuation inputs or other assumptions 268,500 Fair value as of December 31, 2023 $ 447,500 (1) Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liabilities in the statements of operations.

Description Of Organization, _2

Description Of Organization, And Business Operations And Going Concern - Additional Information (Detail) - USD ($)								3 Months Ended	12 Months Ended
	Mar. 21, 2024	Dec. 08, 2023	Sep. 08, 2023	Sep. 07, 2023	Aug. 18, 2023	Feb. 27, 2023	Dec. 09, 2021	Dec. 09, 2023	Dec. 09, 2024	Dec. 31, 2023	Dec. 31, 2022	May 28, 2024	Apr. 08, 2024	Mar. 12, 2024	Feb. 12, 2024	Jan. 24, 2024	Dec. 20, 2023	Nov. 13, 2023	Oct. 19, 2023	Sep. 15, 2023	Aug. 22, 2023	Jun. 22, 2023	May 26, 2023	Mar. 01, 2023	Feb. 28, 2023	Oct. 17, 2022	May 21, 2021
Transaction cost							$ 10,321,097			$ 10,321,097
Underwriting expense paid							3,450,000
Deferred underwriting fee payable noncurrent							6,037,500
Offering cost							$ 833,597
Payment to acquire restricted investments										2,000,000	$ 0
Restricted investments term							185 days
Dissolution expense										100,000
Cash										8,167	413,206
Working capital (deficit)										737,336	200,832
Cash held outside trust account							$ 1,295,936
Operating cash										8,167	413,206
Working capital loan										737,336	200,832
Aggregate redemption amount											2,580,147
Asset held in trust account										62,406,649	177,952,202														$ 68,271,081
Amount deposited into Trust Account for extension of the termination date																	$ 125,000	$ 125,000	$ 125,000	$ 125,000		$ 750,000		$ 750,000
Repayments of Notes Payable					$ 1,625,000					1,625,000	0
Gain (Loss) on Extinguishment of Debt					$ 117,373					$ 117,373	$ 0
Class of warrant or right, outstanding										17,575,000
M&A advisory services [Member] | EarlyBirdCapital, Inc. [Member]
Transaction Fee payable																										$ 2,000,000
Percentage of placement agent fee on equity investment																										4.50%
Percentage of placement agent fee on debt financing amount																										2.50%
M&A advisory services [Member] | EarlyBirdCapital, Inc. [Member] | Letter Amendment [Member]
Transaction Fee payable																					$ 500,000
Promissory Note [Member]
Debt Instrument, Face Amount																									$ 875,000
Second Promissory Note [Member]
Debt Instrument, Face Amount																							$ 750,000
Working Capital Promissory Note [Member]
Debt Instrument, Face Amount			$ 500,000							$ 520,600
Subsequent Event [Member]
Amount deposited into Trust Account for extension of the termination date												$ 125,000	$ 125,000	$ 125,000	$ 125,000	$ 125,000
Further deposits in the trust account due to be made per extension												$ 125,000
Sponsor [Member]
Minimum public share price due to reductions in the value of the trust assets less taxes payable										$ 10
Sponsor [Member] | Founder Shares [Member]
Common stock shares outstanding			970,312
Sponsor [Member] | Promissory Note [Member]
Debt Instrument, Face Amount																											$ 300,000
Sponsor [Member] | Purchase Agreement [Member]
Amount of funds transferred in exchange of warrants or other instruments			$ 1
Amount of transaction to pay expenses			$ 50,000
Related Party [Member]
Due from related parties										$ 25,000
Due to related parties current										0
Sponsor Alliance [Member] | Working Capital Promissory Note [Member]
Proceeds from related party debt										$ 20,600
Minimum [Member]
Percentage of fair market value of target business to asset held in trust account										80%
Percentage of redeeming shares of public shares without the company's prior written consent										15%
Minimum [Member] | Post Business Combination [Member]
Percentage of voting interests acquired										50%
Private Placement Warrants [Member]
Class of warrants and rights issued during the period							8,950,000
Number of securities called by each warrant or right							11.5
Class of warrants and rights issued, price per warrant							$ 1
Proceeds from issuance of private placement							$ 8,950,000
Class of warrant or right, outstanding										8,950,000
Private Placement Warrants [Member] | Sponsor [Member]
Class of warrants and rights issued during the period			6,936,250
Class of warrant or right, outstanding			2,013,750
IPO [Member]
Number of shares issued in transaction							17,250,000
Share price							$ 10
Proceeds from issuance initial public offering							$ 172,500,000
Transaction cost							10,321,097
Underwriting expense paid							3,450,000
Deferred underwriting fee payable noncurrent							6,037,500
Offering cost							833,897
Payment to acquire restricted investments							$ 175,950,000
IPO [Member] | Minimum [Member]
Share price										$ 10
Common Class A [Member]
Common stock shares issued										4,312,500	0
Common stock shares outstanding										4,312,500	0
Common stock par or stated value per share										$ 0.0001	$ 0.0001
Common Class A [Member] | Templar LLC [Member]
Interse transfer of shares	800,000
Common Class A [Member] | IPO [Member]
Number of shares issued in transaction							17,250,000
Share price							$ 10
Proceeds from issuance initial public offering							$ 172,500,000
Number of securities called by each warrant or right										1
Common Class B [Member]
Common stock shares issued										0	4,312,500
Common stock shares outstanding										0	4,312,500
Common stock par or stated value per share										$ 0.0001	$ 0.0001
Common Class B [Member] | Sponsor [Member] | Founder Shares [Member]
Stock issued during period shares			3,342,188
Common stock par or stated value per share			$ 0.0001
Public shares [Member]
Share price										$ 10
Payment to acquire restricted investments								$ 125,000	$ 125,000
Shares exercised, during the period		201,496		757,463		10,693,417
Aggregate redemption amount		$ 2,246,585		$ 8,273,281		$ 111,346,281
Asset held in trust account		$ 62,410,856		$ 63,340,058		$ 68,271,081
Common stock shares issued		5,597,624		5,799,120		6,556,583
Common stock shares outstanding		5,597,624		5,799,120		6,556,583
Minimum deposit in restricted investments based on public share price								$ 0.025	$ 0.025

Revision to Prior Period Fina_3

Revision to Prior Period Financial Statements - Summary Of Audited Financial Statements (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Accrued interest receivable	$ 281,963	$ 577,945
Total Current Assets	290,130	1,128,651
TOTAL ASSETS	62,696,779	179,080,853
Commitments and Contingencies (Note 8)
Class A ordinary shares - 5,597,624 and 17,250,000 shares subject to possible redemption at $11.20 and 10.35 per share redemption value at December 31, 2023 and 2022, respectively	62,688,612	178,530,147
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT	62,696,779	179,080,853
Interest earned on investments in Trust Account	4,024,613	2,579,253
Total Other Income (expense), net	6,001,250	14,533,250
Net income	4,256,395	13,414,455
Remeasurement of Class A ordinary shares to redemption amount	(6,024,613)	(2,580,147)
Net income	4,256,395	13,414,455
Accrued interest receivable	295,982	(577,945)
Remeasurement of Class A ordinary shares subject to possible redemption		2,580,147
Previously Reported [Member]
Current assets:
Accrued interest receivable		0
Total Current Assets		550,706
TOTAL ASSETS		178,502,908
Commitments and Contingencies (Note 8)
Class A ordinary shares - 5,597,624 and 17,250,000 shares subject to possible redemption at $11.20 and 10.35 per share redemption value at December 31, 2023 and 2022, respectively		177,952,202
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT		178,502,908
Interest earned on investments in Trust Account		2,001,308
Total Other Income (expense), net		13,955,305
Net income		12,836,510
Remeasurement of Class A ordinary shares to redemption amount		(2,002,202)
Net income		12,836,510
Accrued interest receivable		0
Remeasurement of Class A ordinary shares subject to possible redemption		2,002,202
Revision of Prior Period, Adjustment [Member]
Current assets:
Accrued interest receivable		577,945
Total Current Assets		577,945
TOTAL ASSETS		577,945
Commitments and Contingencies (Note 8)
Class A ordinary shares - 5,597,624 and 17,250,000 shares subject to possible redemption at $11.20 and 10.35 per share redemption value at December 31, 2023 and 2022, respectively		577,945
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT		577,945
Interest earned on investments in Trust Account		577,945
Total Other Income (expense), net		577,945
Net income		577,945
Remeasurement of Class A ordinary shares to redemption amount		(577,945)
Net income		577,945
Accrued interest receivable		(577,945)
Remeasurement of Class A ordinary shares subject to possible redemption		577,945
Common Class A [Member]
Current assets:
Net income	$ 2,767,853	$ 10,731,564
Basic net income per share	$ 0.35	$ 0.62
Diluted net income share	$ 0.35	$ 0.62
Net income	$ 2,767,853	$ 10,731,564
Common Class A [Member] | Previously Reported [Member]
Current assets:
Basic net income per share		$ 0.6
Diluted net income share		0.6
Common Class A [Member] | Revision of Prior Period, Adjustment [Member]
Current assets:
Basic net income per share		0.02
Diluted net income share		0.02
Class A And Class B Non Redeemable Common Stock [Member]
Current assets:
Basic net income per share	$ 0.35	0.62
Diluted net income share	$ 0.35	0.62
Class A And Class B Non Redeemable Common Stock [Member] | Previously Reported [Member]
Current assets:
Basic net income per share		0.6
Diluted net income share		0.6
Class A And Class B Non Redeemable Common Stock [Member] | Revision of Prior Period, Adjustment [Member]
Current assets:
Basic net income per share		0.02
Diluted net income share		$ 0.02

Revision to Prior Period Fina_4

Revision to Prior Period Financial Statements - Summary Of Audited Financial Statements (Parenthetical) (Detail) - $ / shares	Dec. 31, 2023	Sep. 30, 2023	Feb. 28, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Temporary equity shares outstanding	5,597,624	5,799,120	6,556,583	17,250,000
Temporary Equity, Redemption Price Per Share	$ 11.2			$ 10.35

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Loss Per Common Share (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
EPS
Allocation of net income	$ 4,256,395	$ 13,414,455
Diluted weighted average shares outstanding	17,575,000
Common Class A [Member]
EPS
Allocation of net income	$ 2,767,853	$ 10,731,564
Basic weighted average shares outstanding	8,018,829	17,250,000
Diluted weighted average shares outstanding	8,018,829	17,250,000
Basic net income per ordinary share	$ 0.35	$ 0.62
Diluted net income per ordinary share	$ 0.35	$ 0.62
Common Class B [Member]
EPS
Allocation of net income	$ 1,488,542	$ 2,682,891
Basic weighted average shares outstanding	4,312,500	4,312,500
Diluted weighted average shares outstanding	4,312,500	4,312,500
Basic net income per ordinary share	$ 0.35	$ 0.62
Diluted net income per ordinary share	$ 0.35	$ 0.62

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)			12 Months Ended
	Oct. 02, 2023	Dec. 09, 2021	Dec. 31, 2023	Dec. 31, 2022	Feb. 28, 2023
Cash			$ 8,167	$ 413,206
Cash equivalents at carrying value			0	0
Asset held in trust account			$ 62,406,649	177,952,202	$ 68,271,081
Weighted average number of shares outstanding diluted			17,575,000
Unrecognized tax benefits			$ 0	0
Accrued for interest and penalties			0	0
FDIC Insured Amount			250,000
Transaction cost		$ 10,321,097	10,321,097
Other Offering Cost			465,166
Share Based Compensation expense			$ 0	$ 0
Common Class B [Member]
Conversion of Stock, Shares Converted	4,312,500
Consummation of an Initial Business Combination Event [Member] | Board of Directors [Member]
Stock options shares granted			40,000
Stock options fair value			$ 203,000
Grant date fair value per share			$ 5.08
Compensation expense			$ 203,000
Common Class B [Member]
Weighted average number of shares outstanding diluted			4,312,500	4,312,500
Common stock shares outstanding			0	4,312,500
Conversion of Stock, Shares Converted	4,312,500

Initial Public Offering -Additi

Initial Public Offering -Additional Information (Detail) - USD ($)			3 Months Ended	12 Months Ended
	Sep. 28, 2022	Dec. 09, 2021	Sep. 30, 2022	Dec. 31, 2023
Transaction cost		$ 10,321,097		$ 10,321,097
Underwriting expense paid		3,450,000
Deferred underwriting fee payable noncurrent		6,037,500
Offering cost		$ 833,597
Deferred underwriting commission waived	$ 6,037,500		$ 6,037,500
IPO [Member]
Number of Shares Issued in Transaction		17,250,000
Share price		$ 10
Proceeds from issuance initial public offering		$ 172,500,000
Transaction cost		10,321,097
Underwriting expense paid		3,450,000
Deferred underwriting fee payable noncurrent		6,037,500
Offering cost		$ 833,897
Common Class A [Member] | IPO [Member]
Number of Shares Issued in Transaction		17,250,000
Share price		$ 10
Proceeds from issuance initial public offering		$ 172,500,000
Shares issuable				1
Shares Issued, Price Per Share				$ 0.0001
Common Class A [Member] | Public Warrants [Member] | IPO [Member]
Stock Conversion Basis				one redeemable warrant
Exercise price of warrants or rights				$ 11.5

Private Placement - Additional

Private Placement - Additional Information (Detail) - USD ($)	Sep. 08, 2023	Dec. 09, 2021	Dec. 31, 2023
Class of warrant or right, outstanding			17,575,000
Common Class A [Member] | Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]
Share price			$ 18
Private Placement Warrants [Member]
Class of warrants and rights issued during the period		8,950,000
Class of warrants and rights issued, price per warrant		$ 1
Proceeds from private placement		$ 8,950,000
Class of warrant or right, outstanding			8,950,000
Private Placement Warrants [Member] | Sponsor [Member]
Class of warrants and rights issued during the period	6,936,250
Class of warrant or right, outstanding	2,013,750

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)			12 Months Ended
	Sep. 08, 2023	May 21, 2021	Dec. 31, 2023	Dec. 31, 2022	Feb. 28, 2023
Working Capital Loan [Member]
Debt instrument convertible into warrants			$ 1,500,000
Debt instrument conversion price			$ 1
Promissory Note [Member]
Debt instrument face amount					$ 875,000
Founder Shares [Member]
Common stock threshold percentage on conversion of shares			20%
Sponsor [Member]
Administrative fess expense				$ 6,900
Accounts payable			$ 0	$ 0
Sponsor [Member] | Interse Transfer Of Shares [Member] | Apx Cap Sponsor Group LLC [Member]
Common stock shares outstanding	970,312
Sponsor [Member] | Office Space, Administrative and Support Services [Member]
Related party transaction amounts of transaction			$ 10,000
Sponsor [Member] | Promissory Note [Member]
Debt instrument face amount		$ 300,000
Debt instrument maturity date		May 01, 2022
Debt instrument interest rate		0%
Sponsor [Member] | Founder Shares [Member]
Shares issued shares share-based payment arrangement forfeited		562,500
Common stock threshold percentage on conversion of shares		20%
Common stock shares outstanding	970,312
Common Class B [Member]
Common stock shares outstanding			0	4,312,500
Common stock par or stated value per share			$ 0.0001	$ 0.0001
Common Class B [Member] | Sponsor [Member] | Founder Shares [Member]
Stock issued during period shares issued for services		4,312,500
Stock issued during period value issued for services		$ 25,000
Shares issued shares share-based payment arrangement forfeited			0
Stock issued during period shares	3,342,188
Common stock par or stated value per share	$ 0.0001
Common Class A [Member]
Common stock shares outstanding			4,312,500	0
Common stock par or stated value per share			$ 0.0001	$ 0.0001
Common Class A [Member] | Sponsor [Member] | Share Price More Than Or Equals To USD Twelve [Member]
Share transfer trigger price per share			$ 12
Number of consecutive trading days for determining share price			20 days
Number of trading days for determining share price			30 days
Threshold number of trading days for determining share price from date of business combination			120 days

Promissory Note Payable - Addit

Promissory Note Payable - Additional Information (Detail) - USD ($)			12 Months Ended
	Dec. 31, 2023	Aug. 18, 2023	Dec. 31, 2023	Dec. 31, 2022	Feb. 09, 2024	Sep. 08, 2023	May 26, 2023	Feb. 28, 2023
Debt Instrument [Line Items]
Class Of Warrants Or Rights Issued During The Period				750,000
Repayments of Notes Payable		$ 1,625,000	$ 1,625,000	$ 0
Gain (Loss) on Extinguishment of Debt		$ 117,373	117,373	$ 0
Promissory Note [Member]
Debt Instrument [Line Items]
Debt Conversion, Converted Instrument, Warrants or Options Issued	875,000
Debt instrument face amount								$ 875,000
Promissory Note [Member] | First Extension [Member]
Debt Instrument [Line Items]
Debt instrument face amount								$ 125,000
Second Promissory Note [Member]
Debt Instrument [Line Items]
Debt instrument face amount							$ 750,000
Working Capital Promissory Note [Member]
Debt Instrument [Line Items]
Debt instrument face amount	$ 520,600		520,600			$ 500,000
Working Capital Promissory Note [Member] | Sponsor Alliance [Member]
Debt Instrument [Line Items]
Proceeds from related party debt			$ 20,600
Working Capital Promissory Note [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument face amount					$ 2,000,000
Working Capital Promissory Note [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument face amount					$ 500,000

Commitments And Contingencies -

Commitments And Contingencies - Additional Information (Detail) - USD ($)			3 Months Ended	12 Months Ended
	Sep. 28, 2022	Dec. 09, 2021	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Aug. 22, 2023	Oct. 17, 2022
Underwriting expense paid		$ 3,450,000
Deferred underwriting fee payable noncurrent		$ 6,037,500
Deferred Underwriting Commission Waived	$ 6,037,500		$ 6,037,500
Gain On Settlement Of Underwriting Fees				$ 0	$ 5,788,453
Gain Loss On Settlement Of Deferred Underwriting Fees				0	$ 249,047
Outstanding deferred underwriting commission				0
Sponsor Alliance [Member] | Sponsor Alliance Transaction [Member]
Fee income for services rendered potential business combination				$ 1,625,000
Early Bird Capital, Inc [Member] | MA Advisory Services [Member]
Transaction Fee payable							$ 2,000,000
Structuring Services Agreement [Member] | Early Bird Capital, Inc [Member]
Transaction Fee payable						$ 500,000
Over-Allotment Option [Member]
Over allotment option period		45 days
Stock issued during period shares		2,250,000
Underwriter cash discount		2%
Underwriting expense paid		$ 3,450,000
Percentage of deferred underwriting commission		3.50%
Deferred underwriting fee payable noncurrent		$ 6,037,500

Warrant Liability - Additional

Warrant Liability - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Class of Warrant or Right [Line Items]
Number of warrants or rights outstanding | shares	17,575,000
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]
Class of Warrant or Right [Line Items]
Share redemption trigger price	$ 18
Class of warrant or right exercise price adjustment percentage higher of market value	180%
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Share price	$ 18
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] | Common Class A [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Share price	$ 18
Share Price Equal or Less Nine point Two Rupees per dollar [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right exercise price adjustment percentage higher of market value	115%
Share Price Equal or Less Nine point Two Rupees per dollar [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Share redemption trigger price	$ 9.2
Minimum Percentage Gross Proceeds Required From Issuance Of Equity	60%
Class of warrant or right minimum notice period for redemption	20 days
Class of warrant or right exercise price of warrants or rights	$ 9.2
Share Price Equal or Exceeds Ten point Zero Rupees per dollar [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Share price	$ 10
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrants or rights outstanding | shares	8,625,000
Warrants exercisable term from the date of completion of business combination	30 days
Warrants exercisable term from the closing of IPO	12 months
Minimum lock in period for sec registration from date of business combination	15 days
Private Placement Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrants or rights outstanding | shares	8,950,000
Redemption Of Warrants [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Class of warrants redemption period	30 days
Redemption Of Warrants [Member] | Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Class of warrants redemption price per unit	$ 0.01
Class of warrants redemption notice period	30 days
Class of warrants redemption period	30 days
Share price	$ 18
Redemption Of Warrants [Member] | Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] | Common Class A [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right minimum notice period for redemption	20 days
Redemption Of Warrants [Member] | Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] | Common Class A [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Number of consecutive trading days for determining share price	30 days
Redemption Of Warrants [Member] | Share Price Equal or Exceeds Ten point Zero Rupees per dollar [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Class of warrants redemption price per unit	$ 0.1
Class of warrants redemption notice period	30 days

Shareholders' Deficit - Additio

Shareholders' Deficit - Additional Information (Detail) - $ / shares		12 Months Ended
	Oct. 02, 2023	Dec. 31, 2023	Sep. 30, 2023	Feb. 28, 2023	Dec. 31, 2022
Preferred stock shares authorized		1,000,000			1,000,000
Preferred stock par or stated value per share		$ 0.0001			$ 0.0001
Preferred stock shares issued		0			0
Preferred stock shares outstanding		0			0
Temporary equity shares outstanding		5,597,624	5,799,120	6,556,583	17,250,000
Founder Shares [Member]
Common stock threshold percentage on conversion of shares		20%
Common Class A [Member]
Common stock par or stated value per share		$ 0.0001			$ 0.0001
Common stock shares authorized		200,000,000			200,000,000
Common stock shares issued		4,312,500			0
Common stock shares outstanding		4,312,500			0
Temporary equity shares outstanding		5,597,624			17,250,000
Conversion of Stock, Shares Issued	4,312,500
Common Class B [Member]
Common stock par or stated value per share		$ 0.0001			$ 0.0001
Common stock shares authorized		20,000,000			20,000,000
Common stock shares issued		0			4,312,500
Common stock shares outstanding		0			4,312,500
Common stock, voting rights		one vote
Conversion of Stock, Shares Converted	4,312,500

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption - Summary of Class A Ordinary Shares Subject to Possible Redemption (Detail) - USD ($)			12 Months Ended
	Sep. 30, 2023	Feb. 28, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Temporary Equity [Line Items]
Class A Ordinary Shares Subject to Possible Redemption			$ 62,688,612	$ 178,530,147
Shares redeemed in February 2023	$ (8,273,281)	$ (111,346,281)
Class A Ordinary Shares Subject to Possible Redemption [Member]
Temporary Equity [Line Items]
Class A Ordinary Shares Subject to Possible Redemption			62,688,612	178,530,147	$ 175,950,000
Shares redeemed in February 2023			(111,346,281)
Shares redeemed in September 2023			(8,273,281)
Shares redeemed in December 2023			(2,246,585)
Reameasurement of carrying value to redemption value			$ 6,024,612	$ 2,580,147

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) - USD ($)						12 Months Ended
	Dec. 08, 2023	Sep. 30, 2023	Sep. 07, 2023	Feb. 28, 2023	Feb. 27, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 20, 2023	Nov. 13, 2023	Oct. 19, 2023	Sep. 15, 2023	Jun. 22, 2023	Mar. 01, 2023
Temporary equity accretion to redemption value						$ 2,580,147
Temporary Equity Stock Redeemed During The Period Shares		757,463		10,693,417
Cash Withdrawn from Trust Account Per Share for Redemption Of Shares		$ 10.92		$ 10.41
Cash Withdrawn from Trust Account for Redemption Of Temporary Equity		$ 8,273,281		$ 111,346,281
Temporary equity, shares issued		5,799,120		6,556,583
Temporary equity shares outstanding		5,799,120		6,556,583		17,250,000	5,597,624
Asset held in trust account				$ 68,271,081		$ 177,952,202	$ 62,406,649
Amount deposited into Trust Account for extension of the termination date								$ 125,000	$ 125,000	$ 125,000	$ 125,000	$ 750,000	$ 750,000
Public shares [Member]
Temporary equity accretion to redemption value	$ 2,246,585		$ 8,273,281		$ 111,346,281
Asset held in trust account	$ 62,410,856		$ 63,340,058		$ 68,271,081
Shares exercised, during the period	201,496		757,463		10,693,417
Common stock shares issued	5,597,624		5,799,120		6,556,583
Common stock shares outstanding	5,597,624		5,799,120		6,556,583

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Detail) - USD ($)		Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account		$ 62,406,649	$ 177,952,202
Warrant liability		878,750	351,500
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account	[1]	62,406,649	177,952,202
Fair Value, Inputs, Level 1 [Member] | Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	[2]	431,250	172,500
Fair Value, Inputs, Level 2 [Member] | Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	[2]	$ 447,500	$ 179,000
[1]The fair value of the investments held in Trust Account approximates the carrying amount primarily due to the short-term nature.[2]Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level I measurement during the year ended December 31, 2022 when the Public Warrants were separately listed and traded in an active market. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 measurement during the year ended December 31, 2022, as the key inputs to the valuation model became directly or indirectly observable from the Public Warrants listed price. There were no transfers during the year ended December 31, 2023.

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Fair Value Measurements Inputs (Detail)	Dec. 31, 2023 d yr	Dec. 31, 2022 yr d	Dec. 09, 2021 yr
Risk-free interest rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	3.88	4.08	1.26
Expected term (years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input | yr	0.43	0.83	5
Expected Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.55	0.35	15
Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	11.5	11.5	11.5
Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	11.18	10.27	9.59
Dividend Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0	0
Expected Term to Maturity Date [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input | d	5.2	4.25
Probability of a successful merger [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	90	70

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Changes in the Fair Value of Level 3 Warrant Liabilities (Detail) - Fair Value, Inputs, Level 2 [Member] - Private Placement Warrants [Member]	12 Months Ended
	Dec. 31, 2023 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 179,000
Change in valuation inputs or other assumptions	$ 268,500
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants
Ending balanace	$ 447,500

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - Subsequent Event [Member] - USD ($)	Mar. 21, 2024	Sep. 04, 2024	Aug. 26, 2024
NASDAQ CAPITAL MARKET [Member]
Subsequent Event [Line Items]
Minimum market value of warrants to be maintained		$ 1,000,000
Common Class A [Member] | Sponsor [Member]
Subsequent Event [Line Items]
Stock issued during period shares	800,000
Unsecured Promissory Note [Member]
Subsequent Event [Line Items]
Debt instrument face amount			$ 446,000
Debt instrument interest rate			20%